|
1
|
Bedossa P: Pathology of non-alcoholic
fatty liver disease. Liver Int. 37:85–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brunt EM: Pathology of nonalcoholic fatty
liver disease. Nat Rev Gastroenterol Hepatol. 7:195–203. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Loomba R and Sanyal AJ: The global NAFLD
epidemic. Nat Rev Gastroenterol Hepatol. 10:686–690. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Basaranoglu M, Basaranoglu G and Senturk
H: From fatty liver to fibrosis: A tale of 'second hit'. World J
Gastroenterol. 19:1158–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Robertson G, Leclercq I and Farrel GC:
Nonalcoholic steatosis and steatohepatitis II. Cytochrome P-450
enzymes and oxidative stress. Am J Physiol Gastrointest Liver
Physiol. 281:G1135–G1139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharma RK, Doig MV, Lewis DF and Gibso GG:
Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism
of lipid substrates. Biochem Pharmacol. 38:3621–3629. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leclercq IA, Farrell GC, Field J, Bell DR,
Gonzalez FJ and Robertson GR: CYP2E1 and CYP4A as microsomal
catalysts of lipid peroxides in murine nonalcoholic
steatohepatitis. J Clin Invest. 105:1067–1075. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roman RJ: P-450 metabolites of arachidonic
acid in the control of cardiovascular function. Physiol Rev.
82:131–185. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim D, Cha GS, Nagy LD, Yun CH and
Guengerich FP: Kinetic analysis of lauric acid hydroxylation by
human cytochrome P450 4A11. Biochemistry. 53:6161–6172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Hu J, Zhang C, Jiao Y, Kong X and
Wang W: Analyses of risk factors for polycystic ovary syndrome
complicated with non-alcoholic fatty liver disease. Exp Ther Med.
15:4259–4264. 2018.PubMed/NCBI
|
|
11
|
Shojaee-Moradie F, Cuthbertson DJ, Barrett
M, Jackson NC, Herring R, Thomas EL, Bell J, Kemp GJ, Wright J and
Umpleby AM: Exercise training reduces liver fat and increases rates
of VLDL clearance but not VLDL production in NAFLD. J Clin
Endocrinol Metab. 101:4219–4228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mansouri A, Gattolliat CH and Asselah T:
Mitochondrial dysfunction and signaling in chronic liver diseases.
Gastroenterology. 155:629–647. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hardwick JP: Cytochrome P450 omega
hydroxylase (CYP4) function in fatty acid metabolism and metabolic
diseases. Biochem Pharmacol. 75:2263–2275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuthan H, Tsuji H, Graf H and Ullrich V:
Generation of superoxide anion as a source of hydrogen peroxide in
a reconstituted monooxygenase system. FEBS Lett. 91:343–345. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tripathy D, Mohanty P, Dhindsa S, Syed T,
Ghanim H, Aljada A and Dandona P: Elevation of free fatty acids
induces inflammation and impairs vascular reactivity in healthy
subjects. Diabetes. 52:2882–2887. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lugrin J, Rosenblatt-Velin N, Parapanov R
and Liaudet L: The role of oxidative stress during inflammatory
processes. Biol Chem. 395:203–230. 2014. View Article : Google Scholar
|
|
17
|
Zeng MD, Fan JG, Lu LG, Li YM, Chen CW,
Wang BY and Mao YM: Chinese National Consensus Workshop on
Nonalcoholic Fatty Liver Disease: Guidelines for the diagnosis and
treatment of nonalcoholic fatty liver diseases. J Dig Dis.
9:108–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ricchi M, Odoardi MR, Carulli L, Anzivino
C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni
S, et al: Differential effect of oleic and palmitic acid on lipid
accumulation and apoptosis in cultured hepatocytes. J Gastroenterol
Hepatol. 24:830–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
WHO Expert Consultation: Appropriate
body-mass index for Asian populations and its implications for
policy and intervention strategies. Lancet. 363:157–163. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ip E, Farrell GC, Robertson G, Hall P,
Kirsch R and Leclercq I: Central role of PPARα-dependent hepatic
lipid turnover in dietary steatohepatitis in mice. Hepatology.
38:123–132. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Li S, Zhou Y, Su W, Ruan X, Wang
B, Zheng F, Warner M, Gustafsson JA and Guan Y: Ablation of
cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic
steatosis and fibrosis. Proc Natl Acad Sci USA. 114:3181–3185.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garcia MC, Amankwa-Sakyi M and Flynn TJ:
Cellular glutathione in fatty liver in vitro models. Toxicol In
Vitro. 25:1501–1506. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eid AA, Gorin Y, Fagg BM, Maalouf R,
Barnes JL, Block K and Abboud HE: Mechanisms of podocyte injury in
diabetes: Role of cytochrome P450 and NADPH oxidases. Diabetes.
58:1201–1211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sozen E and Ozer NK: Impact of high
cholesterol and endoplasmic reticulum stress on metabolic diseases:
An updated mini-review. Redox Biol. 12:456–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duwaerts CC and Maher JJ: Mechanisms of
liver injury in non-alcoholic steatohepatitis. Curr Hepatol Rep.
13:119–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zangar RC, Davydov DR and Verma S:
Mechanisms that regulate production of reactive oxygen species by
cytochrome P450. Toxicol Appl Pharmacol. 199:316–331. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsu MH, Savas U, Griffin KJ and Johnson
EF: Human cytochrome p450 family 4 enzymes: Function, genetic
variation and regulation. Drug Metab Rev. 39:515–538. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chavez-Tapia NC, Rosso N and Tiribelli C:
In vitro models for the study of nonalcoholic fatty liver disease.
Curr Med Chem. 18:1079–1084. 2011. View Article : Google Scholar
|
|
30
|
Kang H and Koppula S: Houttuynia cordata
alleviates high-fat diet-induced non-alcoholic fatty liver in
experimental rats. Pharm Biol. 53:414–422. 2015. View Article : Google Scholar
|
|
31
|
Vornoli A, Pozzo L, Della Croce CM,
Gervasi PG and Longo V: Drug metabolism enzymes in a steatotic
model of rat treated with a high fat diet and a low dose of
streptozotocin. Food Chem Toxicol. 70:54–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kohjima M, Enjoji M, Higuchi N, Kato M,
Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, et al:
Re-Evaluation of fatty acid metabolism-related gene expression in
nonalcoholic fatty liver disease. Int J Mol Med. 20:351–358.
2007.PubMed/NCBI
|
|
33
|
Zhou Y, Luo P, Chang HH, Huang H, Yang T,
Dong Z, Wang CY and Wang MH: Colfibrate attenuates blood pressure
and sodium retention in DOCA-salt hypertension. Kidney Int.
74:1040–1048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miyata N, Taniguchi K, Seki T, Ishimoto T,
Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T,
et al: HET0016, a potent and selective inhibitor of 20-HETE
synthe-sizing enzyme. Br J Pharmacol. 133:325–329. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pessayre D: Role of mitochondria in
non-alcoholic fatty liver disease. J Gastroenterol Hepatol.
22(Suppl 1): S20–S27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Byrne CD: Fatty liver: Role of
inflammation and fatty acid nutrition. Prostaglandins Leukot Essent
Fatty Acids. 82:265–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feldstein AE, Werneburg NW, Canbay A,
Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ and Gores GJ: Free
fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha
expression via a lysosomal pathway. Hepatology. 40:185–194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rolo AP, Teodoro JS and Palmeira CM: Role
of oxidative stress in the pathogenesis of nonalcoholic
steatohepatitis. Free Radic Biol Med. 52:59–69. 2012. View Article : Google Scholar
|
|
39
|
Cnop M, Foufelle F and Velloso LA:
Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med.
18:59–68. 2012. View Article : Google Scholar
|
|
40
|
Hui JM, Hodge A, Farrell GC, Kench JG,
Kriketos A and George J: Beyond insulin resistance in NASH:
TNF-alpha or adiponectin? Hepatology. 40:46–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011. View Article : Google Scholar
|
